is the cost of glp 1 going down How Employers Can Manage GLP-1 Costs in Their Health Plans Declining GLP-1 drug prices reveals
Description
Ozempic delivers superior weight loss (12 to 15% body weight vs 2 to 4% with Jardiance) and stronger A1C reduction
These drugs appear safe both for people who currently have cancer and for those with a history of cancer
Viridian: C.
Asia-Pacific market size reached approximately USD 10.47 Billion in 2026, representing 22% share of the GLP-1 Drug Market, supported by large patient base and increasing healthcare access
Mounjaro and Zepbound are both protected from generic competition, giving Eli Lilly full control over pricing with no market pressure to bring costs down
